Home

SEC Filings

SEC Filing Keyword Search (View search tips)
Groupings Filter (View SEC Groupings descriptions)
View Section 16 Filings (3,4,5)
<< First | Previous | Next | Last >>
Filing DateFormDescriptionFiling GroupDownloads
08/14/14424B3Form of prospectus reflecting facts events constituting substantive change from last formRegistration Statements Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
08/14/14424B3Form of prospectus reflecting facts events constituting substantive change from last formRegistration Statements Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
08/14/14424B3Form of prospectus reflecting facts events constituting substantive change from last formRegistration Statements Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
08/14/1410-QQuarterly report which provides a continuing view of a company's financial positionQuarterly Filings Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF Download XBRL Content
07/01/14424B3Form of prospectus reflecting facts events constituting substantive change from last formRegistration Statements Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
07/01/14424B3Form of prospectus reflecting facts events constituting substantive change from last formRegistration Statements Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
07/01/14424B3Form of prospectus reflecting facts events constituting substantive change from last formRegistration Statements Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
07/01/148-KReport of unscheduled material events or corporate eventCurrent Reports Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
06/03/14424B3Form of prospectus reflecting facts events constituting substantive change from last formRegistration Statements Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
06/03/14424B3Form of prospectus reflecting facts events constituting substantive change from last formRegistration Statements Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
<< First | Previous | Next | Last >>
Investor Resources
TNGN(Common Stock)
ExchangeOTC BB (US Dollar)
Price$0.08
Change (%) Stock is Down 0.01 (11.11%)
Volume54,550
Data as of 08/19/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
What's New
August 13, 2014
Tengion Provides Clinical Update and Reports Second Quarter 2014 Financial Results
WINSTON-SALEM, N.C., Aug. 13, 2014 (GLOBE NEWSWIRE) -- Tengion, Inc. (OTCQB:TNGN), a leader in regenerative medicine, today reported key clinical data along with financial and operating results for the quarter ended June 30, 2014. "Today, we are pleased to announce encouraging six-month interim data for the first five patients implanted in the Phase 1 clinical trial of our Neo-Kidney Augment (NKA) cellular therapy being conducted in Sweden. We believe these early trends support the promising... 
May 15, 2014
Tengion Reports First Quarter 2014 Financial Results
WINSTON-SALEM, N.C., May 15, 2014 (GLOBE NEWSWIRE) -- Tengion, Inc. (OTCQB:TNGN), a leader in regenerative medicine, today reported its financial results for the first quarter ended March 31, 2014. "We are actively continuing patient enrollment in our ongoing Phase 1 clinical trials for the Neo-Kidney Augment in both Sweden and in the United States. We are also working with key opinion leaders to determine future development plans for the Neo-Urinary Conduit," commented John L. Miclot, Presi...